KOSUNI CRYPTO
Korea's Crypto Pulse, in English
$BTC $ETH $XRP $SOL $DOGE
Regulation
Neutral

Martin Shkreli Faces Contempt Charges for Violating Lifetime Ban from Pharmaceutical Industry

Published October 13, 2026 11:01 PM · 5 views
Martin Shkreli Faces Contempt Charges for Violating Lifetime Ban from Pharmaceutical Industry

Martin Shkreli has been accused of violating a court order prohibiting his participation in the pharmaceutical industry. The U.S. Federal Trade Commission (FTC) and seven state authorities have requested that a federal judge deem Shkreli in civil contempt. According to documents filed with the court on Tuesday, Shkreli traded shares in pharmaceutical companies despite the 2022 order and posted online opinions regarding the management of several drug firms.

The authorities claim Shkreli publicly traded shares in at least 60 pharmaceutical companies. This follows a prior court ruling that found Shkreli organized an illegal plan to maintain monopoly over Daraprim, leading to his lifetime ban from the pharmaceutical sector. The FTC and states are now asking the court to determine whether he violated the order and impose civil penalties.

Korean Source

This article is an English localization of a Korean-language crypto news report. Original headline: 슈크렐리, 제약업계 영구 퇴출 명령 위반 혐의로 법정모독 신청돼